Готові списки джерел за темами / Human Papillomavirus (HPV) Vaccine

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Добірка наукової літератури з теми "Human Papillomavirus (HPV) Vaccine"

Автор: Grafiati

Опубліковано: 7 червня 2025

Оновлено: 2 серпня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Human Papillomavirus (HPV) Vaccine".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Human Papillomavirus (HPV) Vaccine"

Conageski, Christine. "Human Papillomavirus Vaccines." Clinical Obstetrics & Gynecology 66, no. 3 (2023): 433–47. http://dx.doi.org/10.1097/grf.0000000000000788.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) vaccines are highly effective in preventing the transmission of HPV and thus downstream HPV-related lower genital tract neoplasias. First introduced in 2006, the HPV vaccine has demonstrated clinical efficacy in both men and women. Several commercially available vaccines now exist, but only one is available in the United States. Both prelicensure and postlicensure studies demonstrate robust safety profiles. HPV vaccines should be made available to everyone between the ages of 9 and 26 years of age. Newer vaccination recommendations in expanded populations rely on pat

Стилі APA, Harvard, Vancouver, ISO та ін.

Zakhour, Ramia, Hani Tamim, Farah Faytrouni, Maha Makki, Rayan Hojeij, and Lama Charafeddine. "Determinants of human papillomavirus vaccine hesitancy among Lebanese parents." PLOS ONE 18, no. 12 (2023): e0295644. http://dx.doi.org/10.1371/journal.pone.0295644.

Повний текст джерела

Анотація:

Introduction Human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is responsible for cancer of cervix uteri. Despite its safety and immunogenicity, HPV vaccine hesitancy is one of the most challenging topics that pediatricians face. Methods We aimed to describe the impact of knowledge, attitude, and practice towards vaccines in general, on practice related to HPV vaccination in Lebanon. A questionnaire addressed to parents of students (3–18 years of age) was distributed in 2 public and 2 private schools randomly selected from the greater Beirut area during the scho

Стилі APA, Harvard, Vancouver, ISO та ін.

Cai, Xia, and Ling Xu. "Human Papillomavirus-Related Cancer Vaccine Strategies." Vaccines 12, no. 11 (2024): 1291. http://dx.doi.org/10.3390/vaccines12111291.

Повний текст джерела

Анотація:

Background: Human papillomavirus (HPV) persistent infection is a major pathogenic factor for HPV-related cancers, such as cervical cancer (CC), vaginal cancer, vulvar cancer, anal cancer, penile cancer, and head and neck cancer (HNC). Since the introduction of the world’s first prophylactic HPV vaccine, there has been a decline in the incidence of HPV infections and associated cancers. This article reviews the latest literature on the research progress, efficacy, and safety of HPV vaccines for these cancers, providing a reference for HPV vaccination strategy. Methods: By utilizing databases su

Стилі APA, Harvard, Vancouver, ISO та ін.

Kamolratanakul, Supitcha, and Punnee Pitisuttithum. "Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer." Vaccines 9, no. 12 (2021): 1413. http://dx.doi.org/10.3390/vaccines9121413.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15 HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers. However, cervical cancer remains one of the most common cancers in women, especially in developing countries. Three HPV vaccines have been licensed: bivalent (Cervarix, GSK, Rixensart, Belgium), quadrivalent (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)), and nonavalent (Merck, Sharp & Dome (Merck & Co, Whitehouse Station, NJ, USA)). The current HPV vaccine recommendations apply to 9 years

Стилі APA, Harvard, Vancouver, ISO та ін.

de Sanjosé, Silvia, Laia Alemany, Xavier Castellsagué, and F. Xavier Bosch. "Human Papillomavirus Vaccines and Vaccine Implementation." Women's Health 4, no. 6 (2008): 595–604. http://dx.doi.org/10.2217/17455057.4.6.595.

Повний текст джерела

Анотація:

Countries are now challenged by the rapid development of vaccines aimined at the primary prevention of infections. In the years to come, several vaccines will need to be considered as potential candidates in routine immunization programs. Recently, two new vaccines against two/four types of human papillomavirus (HPV) have been commercialized. Bivalent HPV 16 and 18 (Cervarix™) and quadrivalent HPV 6, 11, 16 and 18 (Gardasil®) vaccines are now extensively used in some countries. These vaccines will prevent infection and long-running complications, such as cervical cancer, other HPV-related canc

Стилі APA, Harvard, Vancouver, ISO та ін.

Kreimer, Aimée R., Deborah Watson-Jones, Jane J. Kim, and Peter Dull. "Single-dose human papillomavirus vaccination: an update." JNCI Monographs 2024, no. 67 (2024): 313–16. http://dx.doi.org/10.1093/jncimonographs/lgae030.

Повний текст джерела

Анотація:

Abstract Human papillomavirus (HPV) vaccines received regulatory approval and were recommended for use in young girls nearly 2 decades ago. Uptake is mostly high in resource-rich settings. In resource-limited settings, where the burden of cervical cancer is disproportionately high, access to and uptake of HPV vaccines are nowhere near satisfactory, despite evidence that HPV vaccination is highly cost-effective and a significant value-for-money investment. The discovery that only a single dose of the HPV vaccines may be needed to confer adequate protection may make equitable access to HPV vacci

Стилі APA, Harvard, Vancouver, ISO та ін.

Toft, Lars, Martin Tolstrup, Merete Storgaard, Lars Østergaard, and Ole S. Søgaard. "Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives." Sexual Health 11, no. 6 (2014): 511. http://dx.doi.org/10.1071/sh14015.

Повний текст джерела

Анотація:

Background Men and women with HIV infection are at increased risk of developing cancers associated with human papillomavirus (HPV). The two licensed prophylactic HPV vaccines protect against de novo infection with HPV-16 and HPV-18, which cause the majority of HPV-associated cancers. Currently, no vaccine efficacy data are available for persons with HIV infection. Nevertheless, some countries have implemented specific HPV vaccination recommendations for HIV-positive populations. To specifically recommend prophylactic HPV vaccination in people with HIV, the vaccines must be safe and immunogenic

Стилі APA, Harvard, Vancouver, ISO та ін.

Cheng, Liqin, Yan Wang, and Juan Du. "Human Papillomavirus Vaccines: An Updated Review." Vaccines 8, no. 3 (2020): 391. http://dx.doi.org/10.3390/vaccines8030391.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination and current clinical trials are also discussed. Currently, more efforts should be put into increasing the vaccine’s coverage, especially in low- and middle-income countries. Provision of education on HPV and vaccination is one

Стилі APA, Harvard, Vancouver, ISO та ін.

Stanley, Margaret. "Tumour virus vaccines: hepatitis B virus and human papillomavirus." Philosophical Transactions of the Royal Society B: Biological Sciences 372, no. 1732 (2017): 20160268. http://dx.doi.org/10.1098/rstb.2016.0268.

Повний текст джерела

Анотація:

Two of the most important human oncogenic viruses are hepatitis B virus (HBV) and human papillomavirus (HPV). HBV infection has been preventable by vaccination since 1982; vaccination of neonates and infants is highly effective, resulting already in decreased rates of new infections, chronic liver disease and hepato-cellular carcinoma. Nonetheless, HBV remains a global public health problem with high rates of vertical transmission from mother to child in some regions. Prophylactic HPV vaccines composed of virus-like particles (VLPs) of the L1 capsid protein have been licensed since 2006/2007.

Стилі APA, Harvard, Vancouver, ISO та ін.

Garland, Suzanne M. "Human papillomavirus vaccines: challenges to implementation." Sexual Health 3, no. 2 (2006): 63. http://dx.doi.org/10.1071/sh06018.

Повний текст джерела

Анотація:

Clinical trials for prophylactic human papillomavirus (HPV) vaccines have shown overwhelmingly positive results. It is expected that with good coverage of the vaccine, 70% of cervical cancers will be prevented, as will a proportion of other HPV-related anogenital diseases. Issues that will require careful consideration will include: whether males and females should be vaccinated; the durability of the immune response; the proportion of attributable disease to the HPV types targetted by the vaccines; and accessibility and cost of the vaccine. Central to an effective vaccination programme will b

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Human Papillomavirus (HPV) Vaccine"

Ebertz, Barika. "Factors influencing women's intentions to obtain the Human Papillomavirus (HPV) vaccine." Thesis, Högskolan Kristianstad, Sektionen för hälsa och samhälle, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:hkr:diva-10745.

Повний текст джерела

Анотація:

Background: Cervical cancer is second most common cancer in women. The 15% incidence of cervical cancer in women worldwide can potentially be reduced by the vaccine against human papillomavirus (HPV). It is therefore important for all healthcare professionals including registered nurses to understand what affects women’s intentions and willingness to receive HPV vaccination so that they can overcome any inappropriate barriers and promote public health. Aim: The aim of this article was to describe factors influencing women’s intentions to obtain the HPV vaccine. Method: The following databases

Стилі APA, Harvard, Vancouver, ISO та ін.

Leung, Tiem-yee, and 梁湉兒. "Literature review on parental acceptability of human papillomavirus (HPV) vaccine." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46939003.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ariyo, Oluwatosin. "Correlates of Human Papillomavirus (HPV) Vaccine Acceptance in Appalachian Tennessee." Digital Commons @ East Tennessee State University, 2017. https://dc.etsu.edu/etd/3238.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection in the U.S., where one HPV-related cancer is diagnosed every 20 minutes. The most common HPV-related cancer is cervical cancer, with an estimated incidence of 12,000 cases annually, a third of which lead to death. Cervical cancer disparately affects women of ethnic minority groups and geographically isolated regions, such as Appalachia. Tennessee ranks third highest in cervical cancer incidence in the country. Many cases of cervical cancer could be prevented through vaccination against HPV, however, vaccination rat

Стилі APA, Harvard, Vancouver, ISO та ін.

Muusha, Prudence. "Prevalence of Human papillomavirus among women following HPV vaccine introduction; a systematic review." Master's thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/29833.

Повний текст джерела

Анотація:

Background: Worldwide efforts have been made by some countries to offer HPV vaccination since its introduction in 2006. Population effectiveness of HPV vaccines is presently an active area of research. We review available evidence on the effectiveness of HPV vaccine uptake among female adolescents to prevent HPV infection. Methods: A comprehensive search of published and grey literature was conducted in several electronic databases using a pre-defined search strategy related to HPV prevalence following vaccination. The database searches were complemented by hand-searches of reference lists of

Стилі APA, Harvard, Vancouver, ISO та ін.

Reveal, Jacqueline Marie, and Jacqueline Marie Reveal. "Increasing HPV Vaccine Provider Recommendations in a Rural Southwest Clinic." Diss., The University of Arizona, 2016. http://hdl.handle.net/10150/622928.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States, however vaccination uptake remains low. One of the known barriers of low vaccination rates is lack of a health care provider recommendation. The purpose of this project was to implement a practice change to increase the number of HPV vaccine recommendations provided by primary care providers (PCPs) to patients aged 9-26 years. The setting for this project was the Little Colorado Physician’s Office, a primary care clinic in rural northern Arizona. Four PCPs, including three family physicia

Стилі APA, Harvard, Vancouver, ISO та ін.

Stridh, Sandra, and Solvind Hammar. "Knowledge of Human papillomavirus (HPV) and attitudes towards HPV-vaccine among Thai female university students." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-214748.

Повний текст джерела

Анотація:

Introduction: Human papillomavirus (HPV) is the most common sexually transmitted infection and causes 529.000 cases of cervical cancer every year. Nowadays, there are vaccines available to prevent infection. Knowledge of HPV influence the attitude towards the vaccine and is therefore a factor of accepting the vaccine. Aim: The aim of this study was to examine the knowledge of HPV and attitudes towards HPV-vaccine among Thai female university students. Method: Descriptive and cross-sectional study with quantitative method using a questionnaire. Purposive sampling was used. The sample consisted

Стилі APA, Harvard, Vancouver, ISO та ін.

Ryan, Chelsea N., Kathryn L. Duvall, Emily C. Weyant, Kiana R. Johnson, and David L. Wood. "Human Papillomavirus Vaccine Uptake, Knowledge, and Acceptance for Youth: A Systematic Review of Appalachia." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/15.

Повний текст джерела

Анотація:

Though vaccine uptake and public support have risen since the release of the first HPV vaccines, the United States has far lower initiation and completion rates for the HPV vaccine series in comparison to other vaccines indicated for youth. Disparities are even greater in the Appalachian regions. Understanding factors contributing to these discrepancies is vital to improving raise vaccine rates in Appalachia. A comprehensive literature search identified all articles pertaining to HPV vaccination in children and adolescents living in Appalachia. The final 15 articles were included in a systemat

Стилі APA, Harvard, Vancouver, ISO та ін.

Olivera-Botello, Gustavo. "Modélisation numérique des aspects immunologiques de la réaction à l’infection à HPV et de la vaccination anti-HPV par Gardasil®." Thesis, Lyon 1, 2011. http://www.theses.fr/2011LYO10038/document.

Повний текст джерела

Анотація:

L’infection au papillomavirus humain (HPV) est connue pour être le principal facteur causal d’une série de maladies aussi bien bénignes (condylomatose ano-génitale, papillomatose lyringée, et autres) que malignes (cancer du col de l’utérus, certains cancers ORL, et autres). Deux vaccins prophylactiques (Gardasil® et Cervarix®) sont sur la marché depuis à peu près quatre ans pour prévenir cette infection. Le présent travail de thèse comportait trois objectifs principaux : i) étudier in-silico l’immunogénicité du vaccin Gardasil® ; ii) étudier in-silico l’histoire naturelle d’une infection à HPV

Стилі APA, Harvard, Vancouver, ISO та ін.

Kornfeld, Julie. "Factors Associated with Acceptance of Human Papillomavirus Vaccine: A Study of Spanish Information Seekers." Scholarly Repository, 2009. http://scholarlyrepository.miami.edu/oa_dissertations/346.

Повний текст джерела

Анотація:

Cervical cancer is the second most common malignancy worldwide. Infection with HPV is a necessary cause of cervical. Hispanic women in the U.S. experience significantly higher rates of invasive disease than non-Hispanic Whites. In this population, HPV vaccines hold significant potential to eliminate further disparities in cervical cancer morbidity and mortality. The purpose of this study was to examine factors associated with Human Papillomavirus (HPV) vaccine acceptability among a national sample of Spanish speaking callers to the National Cancer Institute's (NCI) Cancer Information Service (

Стилі APA, Harvard, Vancouver, ISO та ін.

Holguin, Ashlee Cooper. "Determining the Knowledge & Attitudes of 18-to 26- Year Old Women Regarding Cervical Cancer, Human Papillomavirus, and The Human Papillomavirus Vaccine." DigitalCommons@USU, 2009. https://digitalcommons.usu.edu/etd/464.

Повний текст джерела

Анотація:

This study applied the constructs of the health belief model (HBM) to assess women's knowledge and attitudes (i.e., perceived susceptibility, perceived severity, perceived benefits and perceived barriers) regarding cervical cancer, HPV, and the HPV vaccine and determine whether they predict women's intentions to receive the HPV vaccine. Women aged 18 to 26 years were surveyed from a convenience sample, and were primarily well-educated White women. Using Polytomous Universal Model (PLUM) ordinal regression, it was determined that the constructs of this model could not predict women's intentions

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Human Papillomavirus (HPV) Vaccine"

Nardo, Don. Human papillomavirus (HPV). Lucent Books, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Centers for Disease Control and Prevention (U.S.), ed. Genital human papillomavirus (HPV). Dept. of Health and Human Services, Centers for Disease Control and Prevention, Indian Health Service, 2011.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Miller, Daniel L., and M. Sharon Stack, eds. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-21100-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Syrjänen, Kari J. Human papillomavirus (HPV) involvement in esophageal carcinogensis. Nova Science, 2009.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Syrjänen, Kari J. Human papillomavirus (HPV) involvement in esophageal carcinogenesis. Nova Biomedical Books, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dizon, Don S. Questions & answers about human papilloma virus (HPV). Jones and Bartlett Publishers, 2011.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Gotbaum, Betsy. A better shot at prevention: HPV vaccine more available at city health clinics. Office of the New York City Public Advocate, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kellokoski, Jari. Human papillomavirus (HPV) infections of the oral cavity in women with genital HPV infections. University of Kuopio, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Dizon, Don S. Questions & answers about human papilloma virus (HPV). Jones and Bartlett Publishers, 2011.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kataja, Vesa. Genital human papillomavirus (HPV) infections: Prevalence, incidence, risk factors and prognosis. University of Kuopio, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Human Papillomavirus (HPV) Vaccine"

Dudley, Matthew Z., Daniel A. Salmon, Neal A. Halsey, et al. "Human Papillomavirus (HPV)." In The Clinician’s Vaccine Safety Resource Guide. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-94694-8_10.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Levesque, Roger J. R. "Human Papillomavirus (HPV) and HPV Vaccines." In Encyclopedia of Adolescence. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1695-2_435.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Levesque, Roger J. R. "Human Papillomavirus (HPV) and HPV Vaccines." In Encyclopedia of Adolescence. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-33228-4_435.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Davies, Cristyn, and Kellie Burns. "Human Papillomavirus (HPV) and HPV Vaccine Literacy in Sexualities Education." In The Palgrave Encyclopedia of Sexuality Education. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-030-95352-2_138-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Davies, Cristyn, and Kellie Burns. "Human Papillomavirus (HPV) and HPV Vaccine Literacy in Sexualities Education." In The Palgrave Encyclopedia of Sexuality Education. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-56681-3_138.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bosch, F. Xavier. "Rationale for Human Papillomavirus (HPV) Vaccines." In Emerging Issues on HPV Infections. KARGER, 2006. http://dx.doi.org/10.1159/000092756.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Al Murar, Eiman, Sumiya Taheri, and Shammah Al Memari. "Counseling a Female on the Human Papillomavirus (HPV) Vaccine." In Family Medicine OSCE: First Aid to Objective Structured Clinical Examination. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-5530-5_122.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Markowitz, Lauri E., and Susan Hariri. "Human Papillomavirus Vaccine and Prevention of Human Papillomavirus-Associated Disease in the USA." In The New Public Health and STD/HIV Prevention. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-4526-5_19.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Baezconde-Garbanati, Lourdes, Bibiana Martinez, Carol Ochoa, et al. "Optimizing Engagement of the Latino Community in Cancer Research." In Advancing the Science of Cancer in Latinos. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-14436-3_9.

Повний текст джерела

Анотація:

AbstractTo optimize engagement of Latino communities in cancer research, University of Southern California researchers are working with communities on prevention of cervical cancer, a highly preventable and treatable disease. Two recent studies from their signature initiatives, Es Tiempo and Tamale Lesson, are presented to illustrate the situation in the Latino community regarding the human papillomavirus (HPV) vaccination and cervical cancer screening. These population-based studies included promotores de salud (lay community health workers) and community members who were engaged from concept

Стилі APA, Harvard, Vancouver, ISO та ін.

Thompson, Amelia B., and Lisa C. Flowers. "Human Papillomavirus (HPV)." In Sexually Transmitted Infections in Adolescence and Young Adulthood. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-20491-4_18.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Human Papillomavirus (HPV) Vaccine"

van Dongen, Jeanne E., Laura Folkertsma-Hendriks, Renske D. M. Steenbergen, and Loes I. Segerink. "High-Risk Human Papillomavirus Detection: Towards Multiplex Point-of-Care Detection of HPV Using an Easy-to-use Device." In 2024 IEEE SENSORS. IEEE, 2024. https://doi.org/10.1109/sensors60989.2024.10784566.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Boričić, Katarina, Mirjana Tošić, Zorka Zeba, Tamara Tomašević, and Nevena Milošević. "Awareness, knowledge, and attitudes of human papillomavirus infection and vaccination among students of the University of Belgrade." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24044b.

Повний текст джерела

Анотація:

Background: Human papillomavirus (HPV) infection is the most common sexually transmitted infection, with Serbia experiencing a concerningly high incidence and mortality rate of cervical cancer caused by HPV. Therefore, it is crucial to implement effective public health strategies that should prioritize education and motivation for young people to utilize the available prevention methods. Methods and Objectives: This study aimed to investigate the level of knowledge and awareness among Serbian university students regarding HPV infections, HPV-related diseases, and the HPV vaccine. We conducted

Стилі APA, Harvard, Vancouver, ISO та ін.

Katz, Mira Lynn, Paul L. Reiter, Mack T. Ruffin, and Electra D. Paskett. "Abstract A15: Development of a multilevel human papillomavirus (HPV) vaccine intervention." In Abstracts: Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 9-12, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7755.disp14-a15.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Sepede, Jennifer, and Kathy Chen. "Effect of the COVID-19 Pandemic on HPV Vaccination Rates." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.16_2023.

Повний текст джерела

Анотація:

Human papillomavirus (HPV) is a common sexually transmitted infection that potentiates cancer in both males and females. There are over 200 different types of HPV and while some strains, specifically HPV 6 and 11, may result in genital and skin warts, others remain clinically silent. High risk strains, HPV 16 and 18, are most associated with cervical cancer in women. During the COVID-19 pandemic, there was widespread hesitancy and rejection towards vaccination. Similarly, the Human Papilloma Virus (HPV) vaccine has also been met with distrust since it’s release. Studies have shown that there i

Стилі APA, Harvard, Vancouver, ISO та ін.

Araújo, Simone Rodrigues da Silva, Ludmilla Pinto Guiotti Cintra Abreu, Marilene dos Santos Pereira, et al. "Safety and effectiveness analysis of the HPV vaccine: Comprehensive review." In III Seven International Medical and Nursing Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/iiicongressmedicalnursing-005.

Повний текст джерела

Анотація:

Cervical cancer has become a serious public health problem in Brazil, as it is a slow-developing disease with a high impact on prevalence and mortality rates, especially in women with lower social and economic status who are in the productive period of their lives. It can be triggered by persistent infection with oncogenic subtypes of the Human Papillomavirus, mainly 16 and 18. The objective of this narrative review was to analyze and review the main articles available on the safety and effectiveness of the HPV vaccine. This is a comprehensive review of the literature, with narrative synthesis

Стилі APA, Harvard, Vancouver, ISO та ін.

Орлина, Маргарита Анатольевна, Дмитрий Павлович Вергилесов, Ксения Игоревна Батаева, and Дарья Сергеевна Латышева. "PREVENTION OF HPV INFECTIONS IN ADOLESCENT GIRLS." In Наука как пространство возможностей и развития: сборник статей международной научной конференции (Санкт-Петербург, Апрель 2024). Crossref, 2024. http://dx.doi.org/10.58351/240423.2024.77.79.002.

Повний текст джерела

Анотація:

Вирус папилломы человека: вакцинация как приоритет профилактики является наиболее распространенным вирусом, передающимся половым путем. Он является одной из серьезных проблем здравоохранения во всем мире. Некоторые типы ВПЧ (известные как ВПЧ высокого риска) являются основными этиологическими агентами рака половых путей, таких как рак шейки матки, рак вульвы, влагалища, полового члена и анального канала, а также некоторых видов рака головы и шеи. Вакцинация против ВПЧ является приоритетной задачей в профилактике инфицирования этим вирусом. Однако относительно малая продолжительность применения

Стилі APA, Harvard, Vancouver, ISO та ін.

Katz, Mira L., Jennifer Goodwin, Paul L. Reiter, Mack T. Ruffin, and Electra D. Paskett. "Abstract A23: Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents." In Abstracts: Sixth AACR Conference: The Science of Cancer Health Disparities; December 6–9, 2013; Atlanta, GA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7755.disp13-a23.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Araújo, Amanda Viana de Araújo e., Anna Clara Silva Fonseca, Geovanna Resende de Moraes, Ivan Kevin da Silva Garcia, Beatriz Oliveira Amaro, and Wallex da Silva Guimarães. "The role of health professionals in promoting women's knowledge about HPV and its relationship with cervical cancer." In III Seven International Medical and Nursing Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/iiicongressmedicalnursing-008.

Повний текст джерела

Анотація:

Introduction: Human Papillomavirus (HPV) infections are a significant public health problem, playing a crucial role in the development of cervical cancer (CC). Although 80% to 90% of precursor lesions regress spontaneously, lack of knowledge about the disease, low adherence to immunization, and low adherence to Pap smear testing contribute to high mortality, with cervical cancer being the third most common neoplasm among women in Brazil in 2023, with 17,010 new cases estimated. There are more than 200 types of HPV, with genotypes 16 and 18 being the most oncogenic and associated with cancer. D

Стилі APA, Harvard, Vancouver, ISO та ін.

Osazuwa-Peters, Nosayaba, Kara M. Christopher, Christian Geneus, Rebecca Rohde, Ronald J. Walker, and Mark A. Varvares. "Abstract B58: Assessing university students' sexual risk behavior, knowledge of the human papillomavirus, (HPV), HPV vaccine, and association between HPV and head and neck cancer." In Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-b58.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Kumar, Anoop, Inderjit Singh Yadav, Rupinder Sekhon, Dwaipayan Bharadwaj, and Mausumi Bharadwaj. "Identification of T- and B-cell epitopes in HPV-16 E7 gene isolated from cervical cancer patients." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685256.

Повний текст джерела

Анотація:

Introduction: In India, cervical cancer is the most common cancer among females. Persistence infection with high risk human papillomaviruses (HR-HPV) is an etiological agent for cervical cancer development, especially HPV-16 is found to be exclusively high in cervical cancer cases in Indian population. The continuous expression and transforming ability of HPV E7 helps in progression of cervical cancer and other HPV related disease, which make E7 as a suitable targets for the development of therapeutic vaccines. Objectives: Identification of T-& B-cell epitopes HPV-16 E7 gene isolated from

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Human Papillomavirus (HPV) Vaccine"

Díaz, Lina M., Déborah Martínez Villarreal, Karina Olenka Stella Marquez Guerra, and Carlos Scartascini. Combating Vaccine Hesitancy: The Case of HPV Vaccination. Inter-American Development Bank, 2025. https://doi.org/10.18235/0013410.

Повний текст джерела

Анотація:

Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains one of the leading causes of cancer-related deaths among women in developing countries. Although HPV vaccines are widely available in these regions, vaccine uptake remains persistently low. To address behavioral barriers contributing to this low demand, we evaluated the effectiveness of a behaviorally informed SMS campaign targeting parents in Cali, Colombia. Our study included 15,231 parents, who were randomized into six groups: control, placebo, and four behaviorally informed treatment groups, formi

Стилі APA, Harvard, Vancouver, ISO та ін.

Hassan, Manal. Rapid Scoping Review 2025: Türkiye. Institute of Development Studies, 2025. https://doi.org/10.19088/ids.2025.034.

Повний текст джерела

Анотація:

Anti-feminist discourse has long been present among groups across the political spectrum in Türkiye. Erdoğan has explicitly stated that he is against gender equality, that abortion is murder, and that using contraception undermines the nation. This rhetoric influenced the official stance on reproductive rights, resulting in increasingly limited access to both contraception and preventive health measures such as the human papillomavirus (HPV) vaccine, alongside repeated attempts to restrict or criminalise abortion. This focus on traditional family values led to abolishing the term ‘gender equal

Стилі APA, Harvard, Vancouver, ISO та ін.

Jomah, Arwa, and Afnan Albokhary. The Impact of Human Papillomavirus Vaccine on Women’s Health: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.12.0029.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

van de Sande, Anna, Malika Kengsakul, Margot Koeneman, et al. Imiquimod in cervical dysplasia: a review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0046.

Повний текст джерела

Анотація:

Review question / Objective: To determine the efficacy of topical imiquimod in treatment of high-grade CIN (defined as regression CIN 1 or less), and to determine the clearance rate of high-risk human papillomavirus (hr-HPV), compared to surgical treatment and placebo. Condition being studied: Women with an untreated, histologically proven, CIN2-3 lesion or women who were persistent high-risk HPV positive. Eligibility criteria: Studies that evaluated the efficacy of imiquimod treatment in intraepithelial lesions or malignancy of other organs, and studies published as conference abstract, narra

Стилі APA, Harvard, Vancouver, ISO та ін.

ปทุมราช, สุทธิลักษณ์, ภาวพันธ์ ภัทรโกศล та สัญญา หกพุดซา. ผลของเหงือกปลาหมอดอกขาวต่อการเกิดหลอดเลือดใหม่ และต่อการเติบโตของ เซลล์มะเร็งปากมดลูก ที่ปลูกบนผิวหนังของหนูนู๊ดไมส์ : รายงานฉบับสมบูรณ์โครงการวิจัย. จุฬาลงกรณ์มหาวิทยาลัย, 2011. https://doi.org/10.58837/chula.res.2011.32.

Повний текст джерела

Анотація:

วัตถุประสงค์ของการศึกษาครั้งนี้เพื่อศึกษาผลของสมุนไพรเหงือกปลาหมอดอกขาวที่สกัดด้วยน้ำต่อการเจริญเติบโตและการเกิดหลอดเลือดใหม่ของมะเร็งปากมดลูก โดยทำการศึกษาในหลอดทดลองเพื่อทดสอบผลการยับยั้งการเจริญของเซลล์มะเร็ง และทำการศึกษาในหนูนูดไมซ์ที่ได้รับการปลูกถ่ายเซลล์มะเร็งปากมดลูกใต้ชั้นผิวหนัง โดยเซลล์มะเร็งปากมดลูกที่ใช้เป็นชนิดที่บรรจุสารชีวะพันธุกรรมของฮิวแมนปาปิลโลมาไวรัส ชนิด 16 (Human papillomavirus type 16, (HPV)-16 DNA) และศึกษาผลของสารสกัดสมุนไพรเหงือกปลาหมอต่อชีวะโมเลกุลที่บ่งชี้การเกิดหลอดเลือดใหม่ของมะเร็ง และการตายของเซลล์มะเร็ง ได้แก่ VEGF และ P53 การศึกษาผลของสารสกัดสมุนไพรเหงือกปลา

Стилі APA, Harvard, Vancouver, ISO та ін.

Liu, Yin, Ranran Qie, Yin Wang, and Shaokai Zhang. The Research Progress in Disease Burden of Low-risk Human Papillomavirus (HPV) infection among Males in China: a New Method Exploration in Evidence Mapping. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.6.0051.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Li, Yanhui. Efficacy of non-invasive photodynamic therapy for female lower reproductive tract diseases associated with HPV infection: a comprehensive meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0092.

Повний текст джерела

Анотація:

Review question / Objective: The critical point of this study was to comprehensively evaluate the curative effect of Photodynamic therapy (PDT) in diseases of female lower reproductive tract associated with the human papillomavirus (HPV) infection. Condition being studied: Traditional clinical recommendations for treating diseases of the female lower reproductive tract include topical therapy with drugs, surgery, intravaginal radiation, carbon dioxide (CO2) laser, etc. Although medication is easy to administer, it has a high recurrence rate and adverse effects such as burning sensation, pain,

Стилі APA, Harvard, Vancouver, ISO та ін.

Gidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer244.

Повний текст джерела

Анотація:

Objective. To conduct a systematic review of the literature on the safety of vaccines recommended for routine immunization in the United States, updating the 2014 Agency for Healthcare Research and Quality (AHRQ) report on the topic. Data sources. We searched MEDLINE®, Embase®, CINAHL®, Cochrane CENTRAL, Web of Science, and Scopus through November 9, 2020, building on the prior 2014 report; reviewed existing reviews, trial registries, and supplemental material submitted to AHRQ; and consulted with experts. Review methods. This report addressed three Key Questions (KQs) on the safety of vaccine

Стилі APA, Harvard, Vancouver, ISO та ін.

Cancers Associated with Human Papillomavirus. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control., 2024. https://doi.org/10.15620/cdc/174569.

Повний текст джерела

Анотація:

According to data from 2017 to 2021, an estimated 47,984 new cases of human papillomavirus (HPV)-associated cancers were reported in the United States each year, including 26,280 among females and 21,704 among males. Cervical cancer is the most common HPV-associated cancer among females, and oropharyngeal cancers (cancers of the back of the throat, including the base of the tongue and tonsils) are the most common among males. HPV is a recognized cause of cancer. Although most HPV infections are asymptomatic and clear spontaneously, persistent infections can progress to precancer or cancer. HPV

Стилі APA, Harvard, Vancouver, ISO та ін.

CIOMS Guide to Active Vaccine Safety Surveillance. Council for International Organizations of Medical Sciences (CIOMS), 2017. http://dx.doi.org/10.56759/hnuw8440.

Повний текст джерела

Анотація:

With more vaccine solutions available and opportunities for earlier availability of new vaccine products in resource-limited countries (e.g. vaccines against rotavirus, human papillomavirus or pneumococci) as well as new products that address diseases endemic in those countries only (e.g. malaria, dengue among others), generating reliable data about specific safety concerns is becoming a priority for all countries. The Guide offers a practical step-by-step approach and algorithm to aid immunization professionals and decision-makers in determining the best course of action if additional vaccine

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!